104 related articles for article (PubMed ID: 3260071)
1. Purification of alpha-1-proteinase inhibitor. Preparation and properties of a therapeutic concentrate.
Coan MH
Am J Med; 1988 Jun; 84(6A):32-6. PubMed ID: 3260071
[TBL] [Abstract][Full Text] [Related]
2. Preparation and properties of alpha 1-proteinase inhibitor concentrate from human plasma.
Coan MH; Brockway WJ; Eguizabal H; Krieg T; Fournel M
Vox Sang; 1985; 48(6):333-42. PubMed ID: 3874474
[TBL] [Abstract][Full Text] [Related]
3. Preparation and properties of an alpha-1-protease inhibitor concentrate with high specific activity.
Mattes E; Matthiessen HP; Turecek PL; Schwarz HP
Vox Sang; 2001 Jul; 81(1):29-36. PubMed ID: 11520413
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the liquid and lyophilized formulations of Prolastin®-C for Alpha
Arora V; Cruz M; Lang J; Klos AM; Merritt WK; Price J; Taylor G; Vandeberg P; Wee K; Willis T
Biologicals; 2019 Nov; 62():77-84. PubMed ID: 31522909
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and biological properties of an alpha 1-antitrypsin concentrate.
Burnouf T; Constans J; Clerc A; Descamps J; Martinache L; Goudemand M
Vox Sang; 1987; 52(4):291-7. PubMed ID: 3498260
[TBL] [Abstract][Full Text] [Related]
6. [Blood protein technological industrial developments as a mirror of fundamental studies bgy the Institute of Biochemistry of the Ukrainian National Academy of Sciences].
Volkov GL; Andrianov SI; Horoshnykova TV; Borysevych OS; Gavryliuk OS
Ukr Biokhim Zh (1999); 2000; 72(4-5):109-21. PubMed ID: 11200439
[TBL] [Abstract][Full Text] [Related]
7. Production of alpha 1-proteinase inhibitor (human).
Hein RH; Van Beveren SM; Shearer MA; Coan MH; Brockway WJ
Eur Respir J Suppl; 1990 Mar; 9():16s-20s. PubMed ID: 2340046
[TBL] [Abstract][Full Text] [Related]
8. Chromatographic purification of human alpha 1 proteinase inhibitor from dissolved Cohn fraction IV-1 paste.
Chen SX; Hammond DJ; Klos AM; Wood WD; Wydick JE; Lebing WR
J Chromatogr A; 1998 Mar; 800(2):207-18. PubMed ID: 9561763
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.
Clemmensen I; Petersen LC; Kluft C
Eur J Biochem; 1986 Apr; 156(2):327-33. PubMed ID: 3009181
[TBL] [Abstract][Full Text] [Related]
10. New process for purifying high purity α1-antitrypsin from Cohn Fraction IV by chromatography: A promising method for the better utilization of plasma.
Huangfu C; Zhang J; Ma Y; Jia J; Lv M; Zhao X; Zhang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():156-164. PubMed ID: 28183045
[TBL] [Abstract][Full Text] [Related]
11. Biochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy.
Kolarich D; Turecek PL; Weber A; Mitterer A; Graninger M; Matthiessen P; Nicolaes GA; Altmann F; Schwarz HP
Transfusion; 2006 Nov; 46(11):1959-77. PubMed ID: 17076852
[TBL] [Abstract][Full Text] [Related]
12. Comparative biochemical efficacy analysis of an alpha
Li Z; Franke RM; Morris D; Yel L
Pulm Pharmacol Ther; 2022 Jun; 73-74():102124. PubMed ID: 35314325
[TBL] [Abstract][Full Text] [Related]
13. Biochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous).
Sandhaus RA; Stocks J; Rouhani FN; Brantly M; Strauss P
COPD; 2014 Feb; 11(1):17-25. PubMed ID: 23822603
[TBL] [Abstract][Full Text] [Related]
14. Purification of proteinase-like and Na+/K(+)-ATPase stimulating substance from plasma of insulin-dependent diabetics and its identification as alpha 1-antitrypsin.
Finotti P; Carraro P; Calderan A
Biochim Biophys Acta; 1992 Jun; 1139(1-2):122-32. PubMed ID: 1319211
[TBL] [Abstract][Full Text] [Related]
15. Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases.
Matthiessen HP; Willemse J; Weber A; Turecek PL; Deiteren K; Hendriks D; Ehrlich HJ; Schwarz HP
Transfusion; 2008 Feb; 48(2):314-20. PubMed ID: 18028276
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of a Liquid Formulation of Alpha
Barker AF; Campos MA; Brantly ML; Stocks JM; Sandhaus RA; Lee D; Steinmann K; Lin J; Sorrells S
COPD; 2017 Dec; 14(6):590-596. PubMed ID: 28985109
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.
Kurdowska A; Koj A; Jaśkowska M
Acta Biochim Pol; 1982; 29(1-2):95-103. PubMed ID: 6983800
[No Abstract] [Full Text] [Related]
18. A simple method for the preparation of human serum albumin.
Hao Y
Vox Sang; 1979; 36(5):313-20. PubMed ID: 462920
[TBL] [Abstract][Full Text] [Related]
19. Resistance of horse alpha 1-proteinase inhibitor to perchloric acid denaturation and a simplified purification procedure resulting therefrom.
Pellegrini A; Hägeli G; von Fellenberg R
Biochim Biophys Acta; 1986 Nov; 874(2):144-9. PubMed ID: 3022814
[TBL] [Abstract][Full Text] [Related]
20. Preparation of electroendosmosis-free agarose gel and exemplification of its use in crossed immunoelectrophoresis.
Grubb A
Anal Biochem; 1973 Oct; 55(2):582-92. PubMed ID: 4750692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
